Jefferies Upgrades Sabra Health Care REIT to Buy, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Jonathan Petersen has upgraded Sabra Health Care REIT (NASDAQ:SBRA) from Hold to Buy and raised the price target from $11 to $15.
September 20, 2023 | 9:54 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sabra Health Care REIT has been upgraded to Buy from Hold by Jefferies, with a raised price target of $15, up from $11.
The upgrade from Hold to Buy indicates a positive outlook for Sabra Health Care REIT. The raised price target from $11 to $15 suggests that the analyst expects the stock price to increase in the short term. This could potentially lead to increased investor interest and a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100